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Abstract
Background: Studies in children have shown that concentration of specific serum IgE (sIgE) and size of skin tests
to inhalant allergens better predict wheezing and reduced lung function than the information on presence or
absence of atopy. However, very few studies in adults have investigated the relationship of quantitative atopy with
lung function and airway hyperresponsiveness (AHR).
Objective: To determine the association between lung function and AHR and quantitative atopy in a large sample
of adults from the UK.
Methods: FEV1 and FVC (% predicted) were measured using spirometry and airway responsiveness by
methacholine challenge (5-breath dosimeter protocol) in 983 subjects (random sample of 800 parents of children
enrolled in a population-based birth cohort enriched with 183 patients with physician-diagnosed asthma). Atopic
status was assessed by skin prick tests (SPT) and measurement of sIgE (common inhalant allergens). We also
measured indoor allergen exposure in subjects’ homes.
Results: Spirometry was completed by 792 subjects and 626 underwent methacholine challenge, with 100 (16.0%)
having AHR (dose-response slope>25). Using sIgE as a continuous variable in a multiple linear regression analysis,
we found that increasing levels of sIgE to mite, cat and dog were significantly associated with lower FEV1 (mite p
= 0.001, cat p = 0.0001, dog p = 2.95 × 10-8). Similar findings were observed when using the size of wheal on skin
testing as a continuous variable, with significantly poorer lung function with increasing skin test size (mite p = 8.23
× 10-8, cat p = 3.93 × 10-10, dog p = 3.03 × 10-15, grass p = 2.95 × 10-9). The association between quantitative
atopy with lung function and AHR remained unchanged when we repeated the analyses amongst subjects defined
as sensitised using standard definitions (sIgE>0.35 kUa/l, SPT-3 mm>negative control).
Conclusions: In the studied population, lung function decreased and AHR increased with increasing sIgE levels or
SPT wheal diameter to inhalant allergens, suggesting that atopy may not be a dichotomous outcome influencing
lung function and AHR.
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Background
The association between reduced lung function and
allergen sensitisation (mainly to inhalant allergens) has
been clearly documented, both among children[1-7] and
adults[8], often in the context of high allergen exposure
[1,8]. A similar association has also been demonstrated
for increased airway hyperresponsiveness amongst atopic
individuals compared to those not sensitised[7-13].
Most of the studies investigating the relationship
between allergen sensitisation and lung function or air-
way hyperresponsiveness (AHR) considered atopy as a
simple dichotomous variable, assigning individuals as
atopic or non-atopic based on arbitrary and differing
cut-off points, either for IgE measurement or skin prick
testing. [1-5,8-11]. Similar is the case for the studies
reporting on the association between atopy and wheeze
or other symptoms of allergic disease[14,15]. Analysing
sensitisation quantitatively has been shown to improve
the specificity of these tests. For example, the level of
specific IgE may predict the likelihood of patients having
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symptomatic food allergy[16] and the size of the skin
prick test wheal can be used in a similar way[17]. We
have previously demonstrated similar quantitative rela-
tionship between specific serum IgE levels to common
inhalant allergens and the presence and persistence of
childhood wheezing and reduced lung function[6]. We
have also shown a similar association between increasing
levels of sIgE or size of skin test wheal to inhalant aller-
gens and the presence of childhood allergic rhinitis[18].
However, very few studies in adults have investigated a
quantitative relationship between atopy and lung func-
tion. A study in the US has demonstrated that AHR
increased significantly amongst adult asthmatics with
increasing size of skin test wheals to inhalant allergens
[11]. A significant association was also reported amongst
non-asthmatic individuals with increasing level of mite
specific IgE[12].
We aimed to investigate the associations between the
quantification of atopy (using specific IgE levels and the
size of skin test wheal to a range of common inhalant
allergens) and lung function parameters (FEV1, FVC)
and AHR in a population of adults with and without
asthma, evaluating this in the context of smoking habits
and indoor allergen exposure.
Methods
Study Population
Detailed phenotyping which included information on
symptoms and assessment of lung function, airway reac-
tivity and atopy was carried out amongst parents of chil-
dren enrolled in a population-based birth cohort study
(Manchester Asthma and Allergy Study) [19,20]). We
enriched the study population with carefully phenotyped
asthmatics fulfilling the following criteria: (1) physician-
diagnosed asthma; (2) asthma symptoms (wheeze,
cough, chest tightness, or breathlessness) in the previous
12 months; (3) currently using asthma treatment; and
(4) no asthma exacerbation or respiratory infection
within 4 weeks before the study.[8]. Only subjects of
mixed European origin were included in this analysis.
The study was approved by the Local Research Ethics
Committee. Written informed consent was obtained
from all subjects.
Data sources
Symptoms
A validated questionnaire[21] was interviewer-adminis-
tered to collect information on symptoms, physician-
diagnosed illnesses, treatments received, pet ownership
and smoking habits.
Lung function
FEV1 and FVC were assessed using spirometry accord-
ing to ATS/ERS guidelines[22,23], and expressed as %
predicted.
Airway responsiveness
assessed by methacholine challenge using the 5-breath
dosimeter protocol, as per ATS guidelines[24].
Atopy
We performed skin prick tests (SPT) to D. pteronyssi-
nus, cat, dog, grass pollen mix, tree pollen mix (Staller-
génes, France), and mould mix (Dome-Hollister-Stier,
USA). We measured specific serum IgE (sIgE) to D.
pteronyssinus, cat, dog and grass pollen mix by Immu-
noCAP© (Phadia, Uppsala, Sweden).
Indoor allergen exposure
We visited homes and collected dust samples from the
subjects’ bed and the lounge floor by vacuuming 1 m2
areas for two minutes in a standardised fashion. Mite
(Der p 1), cat (Fel d 1) and dog (Can f 1) allergens were
assayed using enzyme-linked immunoassays[25].
Definition of outcomes and exposures
Current asthma
Physician-diagnosed asthma with asthma symptoms
and/or use of asthma medication in the last 12 months
[26].
Airway hyperresponsiveness (AHR)
expressed as methacholine dose-response slope (MDRS)
[27,28]. Participants were considered to have AHR if
MDRS was >25.
Allergic sensitisation as a dichotomous variable
SPT wheal mean diameter (WMD)≥3 mm compared to
negative control and/or specific IgE (sIgE)>0.35 kUA/l to
any allergen.
Tobacco smoking
Questionnaire information on smoking habits was used
to derive continuous measures of smoke exposure for all
subjects as smoke-pack-years (SPY): non-smokers = 0;
calculated for both current and ex-smokers (SPY=num-
ber of cigarettes smoked per day/20 × number of years
of smoking).
Allergen exposure
Individual exposure to house dust mite (Der p 1), cat
(Fel d 1) and dog (Can f 1) allergens were expressed as
allergen concentration per gram of fine dust (μg/g)[29].
Statistical analysis
The primary outcome measures were lung function
parameters and AHR. All dynamic lung volumes (FEV1
and FVC % predicted and FEV1/FVC) followed a normal
distribution and results are expressed as mean and stan-
dard deviation (SD). Methacholine dose-response slope
(MDRS) distribution was normalised using the transfor-
mation 100/(MDRS+10) = tMDRS[27,30]. The levels of
specific IgE were subject to a loge-transformation prior
to analysis; skin prick tests WMD were used as raw
data. Tobacco smoking and allergen exposure data fol-
lowed a loge-distribution.
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The correlation between SPT-WMD and sIgE levels
for each allergen was assessed using Spearman’s rho
test. The relationship between quantitative sensitisation
and outcome measures was analyzed using linear regres-
sion and General Linear Model Univariate ANOVA,
with a p-value of 0.05 considered as significant. Regres-
sion slope, R2 (as measure of effect direction and size,
respectively) and 95% confidence intervals (95% CI)
were estimated using linear regression models. General
Linear Model multivariate ANCOVA analyses were per-
formed, including all the factors identified as significant
in the univariate analysis. Fitted predicted value curves
according to the level of specific IgE/size of SPT-WMD
were plotted using the results from the regression analy-
sis. Statistical analysis was carried out using SPSS 15.0
(SPSS Inc., Chicago, IN, USA).
Results
Participants
We contacted 1446 parents of the children recruited in
the Manchester Asthma and Allergy Study (population-
based birth cohort representative of the general popula-
tion). Of these, 178 declined the invitation and 99 did not
respond. Of the 1169 subjects who expressed an interest,
831 (71.1%) signed informed consent, of whom 800 were
included in the analysis (12 with insufficient data and 19
non-Caucasians were excluded). We then enriched the
study population with 183 asthmatic patients, with the
analysed sample including 983 Caucasian subjects (416
[42.3%] male; mean age 48.3 years, range 19.8-72.9).
Demographic characteristics of the study population are
presented in Table 1. Skin tests were performed on 730
subjects (74.3%) and 748 (76.1%) provided blood sample
for IgE measurement; 680 subjects had both skin tests
and IgE data. We found no significant differences
between the subjects with and without skin tests and IgE
data in any of the outcomes studied. Spirometry was
done by 792 subjects (80.6%) and 626 (63.7%) underwent
a methacholine challenge, with 100 (16.0%) having AHR
(MDRS>25). Of the 748 subjects with IgE data, 473
(63.2%) were atopic with raised specific IgE to one or
more allergens. Table 2 presents details of atopic status
considering both dichotomous and quantitative defini-
tions. Table 3 presents the correlation between SPT-
WMD and sIgE levels for each allergen.
Specific IgE, Skin Prick tests and Lung Function
Table 4 present the associates of the lung function para-
meters studied. When using IgE measurement to define
subjects as atopic or not (i.e., dichotomous definition),
there was a strong association between atopy and poorer
lung function (FEV1 and FVC % predicted, FEV1/FVC)
and the same was seen when using SPT to define atopy
(Table 4). This was also true when looking at specific
sensitisation to a range of inhalant allergens on either IgE
or SPT, with particularly strong associations with sensitisa-
tion to cat (e.g., for FEV1 % predicted on specific IgE p =
0.0007, on SPT p = 5.02 × 10-7) and dog (for FEV1 % pre-
dicted on SPT p = 4.16 × 10-12, for sIgE p = 8.57 × 10-8).
Using sIgE as a continuous variable in a linear regres-
sion analysis, we found that increasing levels of sIgE to
mite, cat and dog were significantly associated with
poorer level of FEV1 % predicted (for mite p = 0.001,
cat p = 0.0001, dog p = 2.95 × 10-8, Table 4 and Figure
1); the same was also observed for FEV1/FVC, though
only increasing levels of sIgE to dog were associated
with poorer FVC % predicted (Table 4). Similar findings
were observed when using SPT as continuous variable,
with significantly poorer lung function with increasing
size of SPT-WMD for inhalant allergens (Table 4). This
is illustrated for FEV1 % predicted in Figure 2: mite p =
8.23 × 10-8, cat p = 3.93 × 10-10, dog p = 3.03 × 10-15,
grass p = 2.95 × 10-9, mould p = 0.02.
When the levels of specific IgE for the individual aller-
gens (mite, cat, dog, grass) were summed, the strength
of this effect was slightly weakened or lost for FEV1 and
FVC % predicted and FEV1/FVC (p = 0.01, p = 0.17 and
p = 0.002, respectively). However, this was not the case
when adding the sizes of SPT-WMD for the same aller-
gens (FEV1 % predicted p = 1.89 × 10
-15, FVC % pre-
dicted p = 3.20 × 10-6, FEV1/FVC p = 1.99 × 10
-16).
Specific IgE, Skin prick tests and Airway
Hyperresponsiveness
Associates of airway hyperresponsiveness (MDRS) from
univariate regression analysis are shown in Table 5.
Increased MDRS was strongly associated with atopy (on
either SPT or sIgE, p ≤ 3.14 × 10-14) and with sensitisa-
tion to all inhalant allergens tested when using dichoto-
mous definitions (Table 5). When analysing this using
sensitisation as quantitative measure, we found that
increasing levels of sIgE/increasing size of SPT-WMD
were strongly associated with increasing MDRS (Table 5
and Figure 3, illustrative of these associations for sIgE
level). When the levels of sIgE or SPT-WMD sizes to
each individual allergen were summed, this association
remained strongly significant (p = 1.63 × 10-24 for sum
of sIgE or SPT-WMD).
Specific IgE antibodies, Skin Test Size and Lung Function
and Airway Hyperresponsiveness amongst sensitised
subjects
To further Investigate the relationship between quantita-
tive atopy, lung function and AHR, we repeated the ana-
lysis amongst subjects who would be considered
sensitised using standard definitions (e.g., sIgE>0.35
kUa/l, SPT-WMD 3 mm>negative control). Using these
definitions, 473 subjects were assigned as sensitised
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based on sIgE and 402 based on SPT (Table 1). Even
within the group of atopic individuals, increasing level
of sIgE or SPT-WMD size to individual allergens was
associated with significantly poorer lung function or
increasing AHR (data shown for FEV1 % predicted and
MDRS in Table 6).
Multivariate analysis
To assess the relative contribution of sIgE levels and
size of SPT-WMD to lung function (FEV1 % predicted)
and AHR (MDRS), we performed a multivariate
ANCOVA, controlling for all the factors that we found
associated with these outcomes in the univariate ana-
lyses, including current asthma, smoking habits and
indoor allergen exposure. In these models (Table 7),
increasing level of sIgE to dog remained a strong and
highly significant independent associate of FEV1 and
FVC % predicted and FEV1/FVC; the same was true for
increasing level of sIgE/size of SPT-WMD to mite,
which remained an independent associates of MDRS.
Increasing level of sIgE to mite was an independent
associate of FEV1/FVC. The significant independent
associates and the size of their effect varied slightly
depending on whether SPT or sIgE data were used.
Table 1 Characteristics of the 983 subjects included in the study
Variable Total (n)* % of Total Subjects
Age (y) Mean (Range)
48.3 (19.8-72.9) 983 100.0
Gender - male n (%)
416 (42.3) 983 100.0
BMI (%) Mean (SD)
27.2 5.1 769 78.2
Asthma n (%)
Current Asthma 312 (31.74) 983 100.0
Airway Hyperresponsiveness (AHR) n (%)
AHR-MDRS>25 100 (15.97) 626 63.7
GM (Range)
MDRS 8.229 (0.0-17592.5) 626 63.7
Current Asthma with AHR n (%)
Current Asthma + AHR-MDRS>25 64 (10.22) 626 63.7
Lung Function Mean (SD)
FVC % predicted 111.86 (16.01) 790 80.4
FEV1 % predicted 101.20 (18.41) 792 80.6
FEV1/FVC 75.84 (8.71) 790 80.4
Atopy n (%)
SPT 402 55.07 730 74.3
sIgE 473 63.24 748 76.1
Smoking n (%)
Ever smokers 396 (40.28) 983 100.0
Current smokers 114 (11.60) 983 100.0
GM (Range)
Smoke-pack-years 0.0006 (0.0 -104.59) 981 99.8
Pet ownership n (%)
Cat owner (current) 171 21.22 806 81.99
Dog owner (current) 142 17.62 806 81.99
Cat or dog owner (current) 277 34.37 806 81.99
Indoor allergen exposure (μg/g) GM (Range)
Mite (Der p 1) 2.59 (0.20-188.67) 953 96.95
Cat (Fel d 1) 1.42 (0.04-5377.61) 951 96.75
Dog (Can f 1) 0.96 0.20-3361.02) 948 96.44
*Total number of patients with available data; BMI - Body mass index; AHR - Airway Hyperresponsiveness; MDRS - methacholine dose-response slope; SPT - skin
prick tests; sIgE - serum specific Immunoglobulin E; GM - Geometric mean.
Notes: Current Asthma - Physician-diagnosed asthma with asthma symptoms and/or use of asthma medication in the last 12 months[26]; for MDRS, GM
calculated from tMDRS(= 100/(MDRS+10)[27,30]; for smoke-pack-years and indoor allergen exposure, GM calculated from loge transformation.
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Discussion
Principal Findings
Our results confirm that sensitisation to inhalant aller-
gens is an associate of lung function and airway hyper-
responsiveness in adults. Furthermore, our data suggest
that amongst adults there is a quantitative relationship
between the level of allergen-specific IgE or the size of
skin prick test reaction and the level of lung function
and airway hyperresponsiveness, with decreasing lung
function and increasing AHR with increasing level of
specific IgE or skin test wheal size. We have demon-
strated that the absolute level of specific IgE or the size
of the skin test wheal diameter to mite and dog remain
independent associates of lung function and airway
hyperresponsiveness in our sample of adults in the UK
after adjusting for potential confounding variables,
including current asthma, smoking habits and indoor
allergen exposure. In addition, we have extended this
observation in demonstrating that the same associations
remain within the group of subjects defined as atopic
using standard definitions[6].
Limitations and strengths
We were not able to obtain skin prick test data or specific
IgE measurements for all subjects studied (74.3% had skin
tests and 76.1% IgE). However, it is unlikely that this has
influenced our results, since we found no significant differ-
ences between the subjects with and without these data in
any of the outcomes studied. Moreover, the prevalence of
allergic sensitisation among our subjects is similar to that
of young adults in the UK[31], suggesting that our results
are applicable to the general population.
As fewer subjects had skin prick testing data than
measurements of specific IgE, fewer subjects were used
in the analysis of the former, which may account for the
small differences in the results (however, all of the
trends remained the same). Similarly, some subjects in
our study did not do lung function tests of had a metha-
choline challenge; however, there was no difference in
atopy between the groups with and without these tests.
This was a cross-sectional study, and we cannot com-
ment on the role of quantitative measures of allergen-
specific serum IgE or skin prick tests on the change in
lung function or AHR over time. This is an important
question which needs to be addressed in cohort studies,
which are unfortunately lacking in adults.
We acknowledge that the observed associations may
differ between different ethnic groups. We decided to
carry out our analysis amongst Caucasian participants,
as the number of participants of other ethnic origins
was too small to make any meaningful conclusions. We
therefore wish to emphasise that our finding cannot be
extrapolated to other ethnic groups, and further work is
essential to address this important question.
We acknowledge that atopy is strongly associated with
asthma, which could therefore be a confounder. How-
ever, by adjusting for asthma in the multiple regression
models, we were able to take this into account and tease
out independent associations between quantitative
atopy, lung function and AHR. It is also possible that
the association of quantitative atopy with lung function
Table 2 Allergen sensitisation: Dichotomous definitions on SPT and sIgE, SPT wheal mean diameters (WMD, mm) and
sIgE level (kUA/l)
Dichotomous Quantitative Total (n) % of Total Subjects
SPT n (%) Median* (Range)
Mite 256 (35.07) 4.5 (0-19.5) 730 74.26
Cat 175 (23.97) 4.5 (0-20.0) 730 74.26
Dog 112 (15.34) 4.0 (0-16.5) 730 74.26
Tree pollen mix 84 (14.43) 5.0 (0-11.0) 582 59.21
Grass pollen mix 213 (29.18) 5.0 (0-23.0) 730 74.26
Mould mix 32 (4.40) 4.0 (0-12.0) 727 73.96
Specific IgE n (%) GM (Range)
Mite 343 (45.86) 0.48 (0.05-160.77) 748 76.09
Cat 211 (28.21) 0.16 (0.05-146.94) 748 76.09
Dog 170 (22.73) 0.14 (0.05-100.48) 748 76.09
Grass pollen mix 336 (44.92) 2.18 (0.05-407.48) 748 76.09
*Median SPT-WMD among subjects with positive SPTs only (median in whole population = 0 for all allergens due to non-sensitised subjects); GM - Geometric
mean; SPT - skin prick tests.
Note: for specific IgE, GM was calculated based on loge transformation.
Table 3 Correlation between SPT-WMD (mm) and sIgE
levels (kUA/l) for each allergen
Allergen Spearman’s rho p value
Mite 0.734 3.63 × 10-116
Cat 0.696 1.36 × 10-99
Dog 0.548 1.85 × 10-54
Grass pollen 0.644 5.51 × 10-81
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and AHR differs between asthmatics and healthy indivi-
duals. Our study population comprised a sample which
is likely to be representative of the general population
(800 parents of children enrolled in a population-based
birth cohort), enriched by carefully phenotyped asth-
matic subjects, giving us a total of 312 patients with cur-
rent asthma. We enriched the study population with
asthma cases to increase the range of lung function
values and the number of subjects with AHR, and thus
increase the power to detect associations. In addition, by
enriching the study population with well-defined group
of asthmatics, this design has increased our confidence
that we could detect any difference between asthmatics
and non asthmatics. In this population, we did not
observe a significant difference between asthmatics and
non-asthmatics with respect to the findings on the asso-
ciation between quantitative atopy and our outcomes of
interest (i.e. lung function and AHR). However, this
finding needs to be interpreted with great caution, as
our study might not have sufficient power to detect
such differences. This question needs to be addressed in
a much larger study, using for example a matched case-
control design.
Interpretation
Many studies have identified allergic sensitisation (in
particular to inhalant allergens) as a strong associate of
lung function[1-8] and airway hyperresponsiveness
Table 4 Associates of FEV1 and FVC % predicted and FEV1/FVC (univariate analysis)
FEV1 % predicted FVC % predicted FEV1/FVC
Associate P Slope R2 P Slope R2 P Slope R2
Atopy on SPT* 0.00001 -5.93 0.03 0.03 -2.61 0.007 5.39×10-8 -9.81 0.03
Mite Positive SPT 0.00001 -6.27 0.03 0.01 -3.25 0.009 6.17×10-7 -9.76 0.03
SPT-WMD 8.23×10-8 -1.40 0.04 0.002 -0.75 0.01 4.12×10-9 -2.11 0.05
Cat Positive SPT 5.02×10-7 -7.69 0.03 0.02 -2.96 0.007 1.08×10-7 -13.61 0.05
SPT-WMD 3.93×10-10 -1.63 0.05 0.0007 -0.81 0.02 2.80×10-10 -2.55 0.06
Dog Positive SPT 4.16×10-12 -12.22 0.06 0.0001 -6.06 0.02 1.38×10-13 -18.21 0.07
SPT-WMD 3.03×10-15 -2.49 0.08 1.70×10-6 -1.41 0.03 8.53×10-16 -3.68 0.09
Tree Positive SPT 0.73 0.52 0.0002 0.51 0.97 0.0008 0.85 -1.36 0.0005
SPT-WMD 0.93 -0.07 0.00001 0.70 0.02 0.0003 0.37 -0.51 0.002
Grass Positive SPT 2.06×10-6 -6.78 0.03 0.004 -3.64 0.01 2.79×10-7 -9.40 0.03
SPT-WMD 2.95×10-9 -1.04 0.05 0.0002 -0.59 0.02 9.62×10-10 -1.50 0.05
Mould Positive SPT 0.22 -3.22 0.002 0.61 -1.10 0.0004 0.17 -8.17 0.005
SPT-WMD 0.02 -1.53 0.007 0.24 -0.77 0.002 0.006 -2.60 0.01
Atopy on sIgE# 0.0007 -4.83 0.02 0.10 -2.03 0.004 0.0001 -7.22 0.02
Mite Positive sIgE 0.03 -2.97 0.006 0.45 -0.89 0.0008 0.008 -5.31 0.01
sIgE level 0.001 -0.88 0.01 0.21 -0.30 0.002 0.0004 -1.49 0.02
Cat Positive sIgE 0.0007 -5.16 0.02 0.57 -0.75 0.0004 0.00006 -11.76 0.04
sIgE level 0.0001 -1.37 0.02 0.28 -0.33 0.002 0.00003 -2.78 0.04
Dog Positive sIgE 8.57×10-8 -8.70 0.04 0.02 -3.39 0.008 7.30×10-8 -16.05 0.06
sIgE level 2.95×10-8 -2.29 0.04 0.004 -1.04 0.01 1.96×10-7 -3.87 0.06
Grass Positive sIgE 0.04 -2.82 0.006 0.72 -0.42 0.0002 0.002 -5.83 0.01
sIgE level 0.15 -0.38 0.003 0.82 -0.05 0.00007 0.05 -0.84 0.006
Gender - Female 0.09 2.27 0.004 1.00×10-6 5.66 0.03 0.0009 0.02 0.01
Age (years) 1.22×10-13 -0.62 0.07 3.29×10-6 -0.30 0.03 1.31×10-31 -0.005 0.16
BMI (%) 0.0008 -0.42 0.01 4.80×10-9 -0.64 0.04 0.36 0.001 0.001
Current Asthma 1.18×10-41 -17.46 0.21 3.05×10-13 -8.53 0.07 3.68×10-43 -0.08 0.21
Cat ownership (current) 0.32 -1.65 0.001 0.96 -0.12 2.54×10-6 0.10 -0.01 0.003
Dog ownership (current) 0.25 -1.99 0.002 0.68 -0.60 0.0002 0.14 -0.01 0.003
Ln Der p 1 Exposure (μg/g) 0.62 0.17 0.0003 0.33 0.29 0.001 0.68 -0.001 0.0002
Ln Fel d 1 Exposure (μg/g) 0.39 -0.22 0.0010 0.77 0.08 0.0001 0.01 -0.003 0.008
Ln Can f 1 Exposure (μg/g) 0.0001 -1.22 0.02 0.002 -0.87 0.01 0.003 -0.005 0.01
Smoking (Ever) 0.0008 -4.46 0.01 0.07 -2.08 0.004 0.0001 -0.02 0.02
Ln Smoke-Pack-Years 0.0002 -0.31 0.02 0.03 -0.16 0.006 0.0001 -0.002 0.02
*At least one positive skin prick test result; #At least one positive sIgE result; SPT-WMD - Skin prick test wheal mean diameter (mm); sIgE level (kUA/l). BMI - Body
mass index; AHR - Airway Hyperresponsiveness; MDRS - methacholine dose-response slope; SPT - skin prick tests; sIgE - serum specific IgE; GM - Geometric mean.
Current Asthma - Physician-diagnosed asthma with asthma symptoms and/or use of asthma medication in the last 12 months[26].
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[7-13], both in children and in adults, with reduced lung
function and increased airway hyperresponsiveness in
sensitised compared to non-sensitised individuals. How-
ever, as outlined previously, most such studies have con-
sidered sensitisation as either present or not[1-5,8-11]. A
previous study by Burrows and colleagues[13]
investigated the associates of AHR in children, looking
at the sizes of skin test wheals when analysing atopy,
and demonstrated that the sizes of the reactions to mite,
cat, dog and Aspergillus fumigatus were independently
correlated with airway hyperresponsiveness, particularly
when summed. Another study by Nogalo et al.[12]
looked specifically at the associations between airway
hyperresponsiveness and level of specific mite specific
IgE amongst mite-sensitised non-asthmatic children,
and found that these were independently associated.
Our findings add to the above by demonstrating a
quantitative rather than dichotomous relationship
between atopy and the level of lung function and airway
hyperresponsiveness in adults, when using both the size
of skin prick tests and the level of specific IgE to inha-
lant allergens. In multivariate analyses adjusted for other
relevant associates (such as asthma and smoking), we
demonstrated significant independent associations for
quantitative dog skin test and IgE levels and lung func-
tion, with quantitative mite IgE and skin test responses
being associated with airway hyperresponsiveness. It is
important to emphasise that the same quantitative rela-
tionships were demonstrated even when adults without
allergic sensitisation were excluded from the analysis,
confirming the importance of the quantitative approach.
Similar to our previous findings for lower respiratory
symptoms and lung function in children[6], but in
Figure 1 Predicted value for FEV1 % predicted in relation to
sensitization to mite (A), cat (B) and dog (C) - sIgE level (kUA/l),
derived from the linear regression analysis (regression line
with 95% CI).
Figure 2 Predicted value for FEV1 % predicted in relation to sensitization to mite (A), cat (B), moulds (C), dog (D) and grass pollen (E)
- SPT-WMD (mm), derived from the linear regression analysis (regression line with 95% CI).
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contrast to our findings for rhinitis and rhinoconjunc-
tivitis[18], the associations between quantitative atopy
and lung function and airway hyperresponsiveness
remained strongly significant when the IgE levels/sizes
of skin tests for individual allergens (mite, cat, dog and
grass) were summed (with the single exception of the
sum of sIgE levels and lung function parameters).
Clearly, different clinical presentations of allergic
airway disease are associated with different patterns of
quantitative atopy, with the sum of inhalant allergens
being important in childhood wheezing[6], grass pollen
in seasonal and dust mite in perennial rhinitis[18], spe-
cific responses to dog in lung function and specific
responses to dust mite in airway hyperresponsiveness.
Dog allergen is readily inhaled into the lower airways,
and may have an immediate impact on lung function.
Dust mite allergens are carried on much larger
Table 5 Associates of MDRS (univariate analysis)
tMDRS
Associate p Slope R2
Atopy on SPT* 4.27×10-11 -1.43 0.07
Mite Positive SPT 1.05×10-9 -1.43 0.06
SPT-WMD 1.28×10-12 0.033 0.08
Cat Positive SPT 4.31×10-9 -1.55 0.06
SPT-WMD 3.09×10-11 -0.38 0.07
Dog Positive SPT 4.30×10-12 -2.32 0.08
SPT-WMD 3.95×10-12 -0.51 0.08
Tree Positive SPT 0.0001 -1.19 0.03
SPT-WMD 0.0001 -0.23 0.03
Grass Positive SPT 1.27×10-7 -1.31 0.05
SPT-WMD 5.80×10-8 -0.27 0.05
Mould Positive SPT 0.003 -1.92 0.02
SPT-WMD 0.002 -0.48 0.02
Atopy on sIgE# 3.14×10-14 -1.72 0.10
Mite Positive sIgE 1.04×10-11 -1.54 0.08
sIgE level 3.08×10-17 -0.39 0.12
Cat Positive sIgE 4.83×10-16 -2.08 0.11
sIgE level 4.83×10-16 -0.57 0.14
Dog Positive sIgE 2.55×10-21 -2.59 0.15
sIgE level 2.42×10-23 -0.72 0.16
Grass Positive sIgE 7.73×10-13 -1.61 0.09
sIgE level 1.44×10-13 -0.33 0.09
Gender - Female 1.07×10-7 -1.17 0.04
Age (years) 0.39 -0.04 0.001
BMI (%) 0.14 -0.03 0.004
FEV1 % predicted 2.55×10
-28 0.08 0.18
FVC % predicted 0.001 0.03 0.02
FEV1/FVC 1.18×10
-27 15.79 0.18
Current Asthma 3.30×10 -32 -2.89 0.20
Cat ownership (current) 0.42 0.24 0.001
Dog ownership (current) 0.04 -0.61 0.007
Ln Der p 1 Exposure (μg/g) 0.77 0.02 0.0001
Ln Fel d 1 Exposure (μg/g) 0.26 0.06 0.002
Ln Can f 1 Exposure (μg/g) 0.02 -0.13 0.009
Smoking (Ever) 0.08 -0.40 0.005
Ln Smoke-Pack-Years 0.08 -0.03 0.005
*At least one positive skin prick test result; #At least one positive sIgE result;
SPT-WMD - Skin prick test wheal mean diameter (mm); sIgE level (kUA/l)
BMI - Body mass index; MDRS - methacholine dose-response slope; SPT - skin
prick tests; sIgE - serum specific IgE. Current Asthma - Physician-diagnosed
asthma with asthma symptoms and/or use of asthma medication in the last
12 months[26].
Note: tMDRS = 100/(MDRS+10), thus negative slope means increasing MDRS
Figure 3 Predicted value for MDRS in relation to sensitization
to mite (A), cat (B), dog (C) and grass pollen (D) - sIgE level
(kUA/l), derived from the linear regression analysis (regression
line with 95% CI). Note: analysis done with tMDRS (= 100/(MDRS
+10), with converted values shown in Y axis, hence inverted scale.
Table 6 Quantification of IgE and SPT and FEV 1 %
predicted and tMDRS amongst sensitised subjects
(univariate analysis)
FEV1 % predicted tMDRS
p Slope R2 p Slope R2
SPT-WMD
Mite 0.001 -1.33 0.04 0.001 -0.19 0.03
Cat 2.26×10-6 -1.41 0.05 1.57×10-5 -0.27 0.06
Dog 3.69×10-11 -2.43 0.1 2.64×10-6 -0.37 0.07
Tree 0.84 0.07 0.0001 0.08 -0.12 0.01
Grass 3.77×10-6 -1.04 0.05 0.03 -0.11 0.01
Mould 0.17 -0.99 0.005 0.09 -0.29 0.009
sIgE
Mite 0.09 -0.50 0.004 6.08×10-6 -0.28 0.06
Cat 0.01 -1.05 0.01 1.14×10-10 -0.46 0.12
Dog 9.33×10-6 -2.08 0.04 2.90×10-12 -0.59 0.13
Grass 0.35 0.34 0.002 0.02 -0.19 0.03
SPT-WMD - Skin prick test wheal mean diameter (mm); sIgE level (kUA/l)
SPT - skin prick tests; sIgE - serum specific IgE
Note: tMDRS = 100/(MDRS+10), thus negative slope means increasing MDRS
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particles and may contribute to the chronic inflamma-
tory process best represented by airway hyperrespon-
siveness. The importance of dog and mite allergens in
this study may also reflect the high concentrations of
these allergens in UK homes. Our findings for lung
function and airway hyperresponsiveness are consistent
with recent studies demonstrating that quantification
of IgE may be useful not only to diagnose allergic dis-
eases in young children but to serve as a marker of
persistence of wheeze[6] and severity of asthma[32,33].
Conclusions
In our study population, we observed a quantitative rela-
tionship between IgE-mediated sensitisation and lung
function or airway hyperresponsiveness in adults. Our
results have important implications in clinical practice:
the quantification of allergic sensitisation may offer
more information to the clinician compared to the sim-
ple presence or absence of atopy.
Abbrevations
AHR: Airway hyperresponsiveness; BMI: Body mass index; FEV1: Forced
expiratory volume in one second; FVC: Forced vital capacity; MDRS:
Methacholine dose-response slope; sIgE: specific serum immunoglobulin E;
SPT: Skin prick tests; SPT-WMD: Skin prick test wheal mean diameter; SPY:
Smoke pack years.
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Table 7 Independent associates of lung function and AHR
(multivariate analysis)
FEV1 % predicted
Associate Model 1 (SPT-WMD) Model 2 (sIgE level)
Adj p Adj R2 Adj p Adj R2
Age 5.82×10-7 0.04 5.91×10-8 0.04
BMI 0.09 0.48
Current Asthma 1.64×10-14 0.08 3.34×10-24 0.14
Ln Smoke-Pack-Years 0.02 0.008 0.02 0.008
Ln Can f 1 exposure 0.06 0.07
Mite 0.16 0. 69
Cat 0.91 0.46
Dog 0.003 0.01 0.10
Grass 1.00 NI
Mould 0.11 NA
FVC % predicted
Associate Model 1 (SPT-WMD) Model 2 (sIgE level)
Adj p Adj R2 Adj p Adj R2
Age 0.01 0.009 0.01 0.009
BMI 3.65×10-5 0.03 6.23×10-5 0.02
Gender - female 0.0003 0.02 0.001 0.02
Current Asthma 0.0002 0.02 2.91×10-8 0.04
Ln Smoke-Pack-Years 0.44 0.45
Ln Can f 1 exposure 0.18 0.13
Mite 0.49 NI
Cat 0.91 NI
Dog 0.047 0.006 0.56
Grass 0.94 NI
FEV1/FVC
Associate Model 1 (SPT-WMD) Model 2 (sIgE level)
Adj p Adj R2 Adj p Adj R2
Age 9.99×10-20 0.12 2.51×10-23 0.13
Gender - female 0.02 0.008 0.01 0.009
Current Asthma 8.08×10-15 0.09 8.52×10-21 0.12
Ln Smoke-Pack-Years 0.004 0.01 0.004 0.01
Ln Can f 1 exposure 0.20 0.33
Ln Fel d 1 exposure 0.27 0.24
Mite 0.02 0.008 0.21
Cat 0.84 0.72
Dog 0.003 0.01 0.47
Grass 0.96 NI
Mould 0.23 NA
tMDRS
Associate Model 1 (SPT-WMD) Model 2 (sIgE level)
Adj p Adj R2 Adj p Adj R2
Gender - female 3.59×10-13 0.09 3.97×10-13 0.09
Current Asthma 3.82×10-7 0.05 0.0003 0.02
FEV1 % predicted 60.3×10
-9 0.06 1.04×10-8 0.06
FEV1/FVC 0.001 0.02 2.05×10
-5 0.03
Ln Can f 1 exposure 0.25 0.32
Mite 0.0001 0.03 0.0004 0.02
Cat 0.36 0.45
Table 7 Independent associates of lung function and AHR
(multivariate analysis) (Continued)
Dog 0.56 0.44
Grass 0.20 0.007 0.01
Mould 0.30 NA
Models using quantitative measures of sensitisation to inhalant allergens:
either SPT-WMD in mm for Model 1 or level of sIgE in kUA/l for Model 2.
BMI - body mass index; tMDRS - transformed methacholine dose-response
slope (tMDRS = 100/(MDRS+10); SPT - skin prick tests; sIgE - serum specific
IgE.
Current Asthma - Physician-diagnosed asthma with asthma symptoms and/or
use of asthma medication in the last 12 months[26].
NA - not available; NI - not included in model (no association in univariate
analysis)
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